Practice test 12 for Section B: Strategic Management covering Strategic Analysis: Internal Environment, Strategic Choices.
8 questions across 2 chapters, 15 marks and 30 minutes in the timed paper. Every answer below is shown with the working behind it and the authority it rests on.
Law and standards used: ICAI Study Material for CA Intermediate Paper 6: Financial Management and Strategic Management (relevant for January 2027 attempt).
Questions
8
Marks
15
Time limit
30 minutes
Attempt
January 2027
Group
Group 2
Law basis
ICAI Study Material for CA Intermediate Paper 6: Financial Management and Strategic Management (relevant for January 2027 attempt)
Content as of
2026-11-04
Chapters covered
Strategic Analysis: Internal Environment (3 Q)
Strategic Choices (5 Q)
Questions, answers and explanations
Question 1 · 2 marks · Strategic Analysis: Internal Environment · medium
Scenario. BioHealth Pharma holds patented molecular formulations and a clinical research pipeline. The strategic team applies the VRIO framework to assess whether these resources can support sustained competitive advantage.
BioHealth Pharma owns patented molecular formulations with legal protection and tacit process know-how. Under VRIO, which combination most directly indicates potential sustained advantage?
Valuable, rare and costly to imitate (correct answer)
Valuable and common across rivals
Rare but not supported by organization
Easily imitable and substitutable
Answer: A — Valuable, rare and costly to imitate
Working. VRIO test for patented formulations: valuable yes, rare yes, costly to imitate yes due legal protection and tacit know-how, and organization support must then be examined.
Explanation. VRIO requires value, rarity, costly imitability and organization. Option a is correct because patents and tacit know-how support value, rarity and costly imitation. Option b lacks rarity. Option c fails organization. Option d fails imitability and non-substitutability.
Where it goes wrong. Treating a patent as an automatic sustained advantage without checking organization and value.
Question 2 · 2 marks · Strategic Analysis: Internal Environment · hard
The clinical research pipeline is valuable and rare but data exclusivity is temporary and key scientists are mobile. Which VRIO outcome is most appropriate?
Sustained competitive advantage
Temporary competitive advantage (correct answer)
Competitive parity
Competitive disadvantage
Answer: B — Temporary competitive advantage
Working. VRIO assessment: valuable yes, rare yes, costly to imitate limited by temporary exclusivity and mobility, organization may help but durability is limited, so advantage is temporary.
Explanation. Valuable and rare resources can create advantage, but temporary exclusivity and mobile scientists make imitation and transfer easier. Option b is correct. Option a overstates durability and imitability protection. Option c ignores value and rarity. Option d ignores the positive resource attributes.
Where it goes wrong. Assuming every rare resource yields sustained advantage even when imitability and durability are weak.
Question 3 · 2 marks · Strategic Analysis: Internal Environment · medium
To convert VRIO resources into sustained advantage, BioHealth Pharma should focus on which action?
Reduce complementary assets and routines
Imitate rivals
Organize complementary assets, routines and incentives to exploit resources (correct answer)
Disclose patents to competitors
Answer: C — Organize complementary assets, routines and incentives to exploit resources
Working. VRIO logic: after value, rarity and costly imitability are present, organization is required to capture returns and sustain advantage.
Explanation. The O in VRIO refers to organization. Option c is correct because complementary assets, routines and incentives allow the firm to exploit valuable, rare and costly-to-imitate resources. Option a weakens exploitation. Option b destroys advantage. Option d reduces costly imitability.
Where it goes wrong. Confusing resource ownership with organization and exploitation capability.
Scenario. Reliance Enterprises evaluates growth moves. It considers acquiring a fly-ash processing unit that supplies raw material to its cement plants and also considers an unrelated hotel chain acquisition. The board examines concentric and conglomerate diversification.
Reliance Enterprises, a cement producer, acquires a fly-ash processing unit that supplies raw material to its existing cement plants. This is most appropriately classified as:
Answer: D — Vertical backward concentric diversification
Working. Classification test: related to existing business yes; input supply stage yes; backward in value chain yes; concentric linkage through process yes.
Explanation. The fly-ash unit supplies an input to existing cement plants, so it is backward in the value chain and related to existing process. Option d is correct. Option a is unrelated diversification. Option b is at the same stage of production. Option c is an Ansoff market move, not an input-supply acquisition.
Where it goes wrong. Calling every acquisition conglomerate diversification and ignoring value-chain linkage.
Explanation. Conglomerate diversification is entry into unrelated products, services or markets with no common thread in product, market or technology. Option a is correct. Option b requires relatedness. Option c requires movement into distribution or buyer lines. Option d is an existing product in existing markets.
Where it goes wrong. Assuming a large unrelated acquisition is forward integration because it is a new business.
Which statement about risk reduction in conglomerate diversification is most appropriate?
It creates operating synergy through shared technology
It can reduce total risk by combining imperfectly correlated cash flows but may dilute strategic fit (correct answer)
It eliminates business risk
It always increases shareholder value
Answer: B — It can reduce total risk by combining imperfectly correlated cash flows but may dilute strategic fit
Working. Risk logic: total risk can fall when cash flows are imperfectly correlated; synergy and fit are not automatic in unrelated businesses.
Explanation. Unrelated diversification can reduce total risk through imperfect correlation of cash flows, but it lacks operating linkage and may dilute strategic fit. Option b is correct. Option a describes related diversification. Option c overstates risk elimination. Option d ignores execution and fit risks.
Where it goes wrong. Treating unrelated diversification as an automatic value creator and ignoring lack of strategic fit.
Scenario. A manufacturing firm shows signs of distress and considers a turnaround strategy. The management reviews early warning signals and operational turnaround actions before deciding on liquidation or divestment.
Which is an early warning sign of distress at a manufacturing firm considering turnaround?
Explanation. ICAI turnaround indicators include persistent negative cash flow, declining market share, uncompetitive products and low morale. Option c is correct. Options a, b and d are positive signals, not distress signals.
Where it goes wrong. Looking only at accounting profit and ignoring negative operating cash flow.
Which action is most consistent with an operational turnaround?
Immediate liquidation
Unrelated diversification
Increasing dividend payout
Cost reduction, working capital improvement and pruning weak product lines (correct answer)
Answer: D — Cost reduction, working capital improvement and pruning weak product lines
Working. Turnaround action plan includes assessment of problems, strategic plan, emergency action, restructuring and return to normal; operational actions include cost reduction, working capital improvement and product pruning.
Explanation. Operational turnaround focuses on improving internal efficiency through cost reduction, working capital improvement, budgeting and product-line pruning. Option d is correct. Option a is liquidation. Option b is unrelated growth. Option c worsens cash conservation.
Where it goes wrong. Choosing divestment or liquidation before attempting operational turnaround actions.
